Skip to main content
Table of Contents
Print

Can Cannabis Use Improve Outcomes in EDS Rehabilitation Programmes? 

Author: Dr. Clarissa Morton, PharmD

For individuals with Ehlers-Danlos Syndrome (EDS), rehabilitation programmes are often a key part of managing symptoms and improving quality of life. As the search for more effective therapies continues, the question arises: can EDS rehab outcomes with cannabis be a game-changer for those undergoing physical therapy and rehabilitation? 

While rehab programmes are essential for addressing the physical challenges of EDS, many patients find the process to be slow and painful. The idea of incorporating cannabis into these programmes has gained attention, with the potential to enhance both the therapeutic experience and outcomes. 

How Cannabis May Support EDS Rehab Programmes 

Here’s how EDS rehab outcomes with cannabis may improve, offering added support and therapy enhancement for patients: 

  • Pain Relief: 
    One of the most common hurdles in rehab programmes for EDS patients is managing the intense pain associated with the condition. Cannabis, particularly CBD, is known for its pain relieving properties and may help reduce the discomfort experienced during therapy. This could allow patients to engage more effectively in rehabilitation without being hindered by pain. 
  • Muscle Relaxation and Mobility: 
    EDS often leads to joint instability and muscle weakness, making physical therapy challenging. Cannabis, especially strains with a balance of CBD and THC, may aid in muscle relaxation and improve mobility. By easing tension in muscles and joints, cannabis could support better range of motion, making rehab exercises more productive and less taxing. 
  • Mood Regulation and Motivation: 
    Depression and anxiety are common in those with EDS, and these mental health challenges can significantly impact rehabilitation efforts. Cannabis has been reported to help with mood regulation, which could offer outcome support in motivating patients to stay committed to their rehabilitation programmes. 
  • Reduced Inflammation: 
    Inflammation plays a significant role in the discomfort and dysfunction experienced by EDS patients. Cannabis, particularly CBD, has anti-inflammatory properties that could help reduce swelling and improve overall rehabilitation progress. 

While cannabis may offer promising benefits, its use in EDS rehab programmes should always be discussed with healthcare providers to ensure it complements individual treatment plans.  

Providers like LeafEase can guide patients in exploring cannabis use as part of their rehabilitation journey. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Ehlers-Danlos Syndrome. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories